摘要:
Provided is a regenerative cell extraction system. The regenerative cell extraction system includes: a regenerative cell separation unit which separates fat tissue; and a regenerative cell extraction unit. The regenerative cell separation unit includes: a sub container which is rotated by a torque applied from an external source and includes a space in which fat tissue is housed; a hollow main pipe which is inserted into the sub container; and a pump which is connected to the main pipe. In addition, the regenerative cell extraction unit receives a regenerative cell-containing substance, which is obtained after the fat tissue is centrifuged by the regenerative cell separation unit, from the regenerative cell separation unit, and extracts regenerative cells from the substance by centrifuging the substance. The regenerative cell extraction unit includes: a main container which is rotated by a torque applied from an external source; a hollow first discharge pipe which is inserted into the main container; and a suction device which is connected to the first discharge pipe; and a plurality of protruding housing portions which bulge outwards along a radius direction with respect to a center of rotation of the main container to accommodate relatively heavy components among components separated from the substance.
摘要:
A device for generating a pumping voltage and preventing an excessive increase in the pumping voltage includes a pumping voltage output unit that outputs a pumping voltage and adjusts the level of the pumping voltage in order to maintain a target voltage. The level of the pumping voltage is adjusted in response to a change in the level of the pumping unit. A release unit is included to detect an excessive pumping voltage. The release unit adjusts the level of the pumping voltage when the pumping voltage reaches a predetermined excessive level by compulsively decreasing the pumping voltage to prevent damage in the DRAM.
摘要:
A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要:
A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要:
Provided is a regenerative cell extraction system. The regenerative cell extraction system includes: a regenerative cell separation unit which separates fat tissue; and a regenerative cell extraction unit. The regenerative cell separation unit includes: a sub container which is rotated by a torque applied from an external source and includes a space in which fat tissue is housed; a hollow main pipe which is inserted into the sub container; and a pump which is connected to the main pipe. In addition, the regenerative cell extraction unit receives a regenerative cell-containing substance, which is obtained after the fat tissue is centrifuged by the regenerative cell separation unit, from the regenerative cell separation unit, and extracts regenerative cells from the substance by centrifuging the substance. The regenerative cell extraction unit includes: a main container which is rotated by a torque applied from an external source; a hollow first discharge pipe which is inserted into the main container; and a suction device which is connected to the first discharge pipe; and a plurality of protruding housing portions which bulge outwards along a radius direction with respect to a center of rotation of the main container to accommodate relatively heavy components among components separated from the substance.
摘要:
The present invention provides an aqueous formulation of human erythropoietin having the storage stability over a long period without serum albumin, in which the formulation comprises a pharmaceutically effective amount of human erythropoietin; non-ionic surfactant, polyhydric alcohol, neutral amino acid and sugar alcohol as stabilizers; isotonic reagent; and buffering reagent.
摘要:
The internal voltage generation circuit includes an internal voltage enable signal generation unit generating an internal voltage enable signal whose enable pulse width is controlled according to an external voltage. An internal voltage generation unit generates an internal voltage corresponding to a reference voltage according to the internal voltage enable signal. The internal voltage generation circuit generates an internal voltage according to an internal voltage enable signal whose enable pulse width is controlled in response to an external voltage, and thus current consumption is improved, and the internal voltage generation circuit provides a stable internal voltage.
摘要:
A semiconductor memory device can generate an under_drive voltage that maintains a predetermined level stably even in case of a change in the operation mode of the semiconductor memory device or the level of an external power supply voltage. The semiconductor memory device, which includes an external power supply voltage detector configured to detect a level of an external power supply voltage to generate the external voltage detection signal, an under_drive voltage detector configured to detect a voltage level of an under_drive voltage to generate the under_drive voltage detection signal, and an under_drive voltage generator configured to generate the under_drive voltage in response to the under_drive voltage detection signal with a variable driving force in response to the external voltage detection signal.
摘要:
A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要:
The present invention relates to a radial disk type ion mobility spectrometer, comprising: an ionizing chamber which is made of a cylindrical tube, and includes an inlet for supplying sample gas therethrough, an ionizing means for ionizing the supplied sample gas to generate ions having a predetermined polarity, and a slit formed by cutting away a part of a cylindrical wall corresponding to a predetermined width for discharging the ions therethrough; a shutter grid installed adjacent to the slit of the ionizing chamber for controlling passage of the ions through the slit; a drift chamber which is a hollow tube having a predetermined thickness and including an outer cylindrical wall having a predetermined diameter and an inner cylindrical wall having an inner diameter equal to an outer diameter to the ionizing chamber so that an annular space is formed between the inner and outer cylindrical walls, of which a part of the inner cylindrical wall corresponding to a width larger than that of the slit is cut away such that the ions passing through the slit can be introduced into the annular space through the cutaway part of the inner cylindrical wall, and of which the inner cylindrical wall is engaged with the cylindrical wall of the ionizing chamber in such a manner that the drift chamber communicates with the ionizing chamber through the slit and the cutaway part of the inner cylindrical wall; and a collector installed onto an inner surface of the outer cylindrical wall of the drift chamber for collecting the ions that have passed through the drift chamber.